中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

35 records (took 0.021 seconds)

    Method of treating a defective heart valve
    21.
    发明授权
    Method of treating a defective heart valve 有权

    公开(公告)号：US11141274B2

    公开(公告)日：2021-10-12

    申请号：US17028719

    申请日：2020-09-22

    Applicant: Edwards Lifesciences Corporation

    Inventor： David L. Hauser ,  Jan Otto Solem ,  David Alon

    IPC: A61F2/24

    Abstract: A method of treating a defective heart valve includes inserting a delivery catheter through a small incision in a patient's groin, wherein the delivery catheter has a prosthetic device positioned along a distal end. The prosthetic device includes an insert member and an anchoring member. The insert member is positioned between the native heart valve and is allowed to self-expand. The anchoring member is preferably a stent connected to the insert member by at least one elongate member. The stent is deployed within an adjacent blood vessel for anchoring the insert member between the native leaflets. After deployment of the prosthetic device, the native leaflets of the heart valve form a tight seal against the insert member for preventing regurgitation through the native heart valve during ventricular systole.

    METHOD OF TREATING A DEFECTIVE HEART VALVE
    22.
    发明申请
    METHOD OF TREATING A DEFECTIVE HEART VALVE 有权

    公开(公告)号：US20210015608A1

    公开(公告)日：2021-01-21

    申请号：US17028719

    申请日：2020-09-22

    Applicant: Edwards Lifesciences Corporation

    Inventor： David L. Hauser ,  Jan Otto Solem ,  David Alon

    IPC: A61F2/24

    Abstract: A method of treating a defective heart valve includes inserting a delivery catheter through a small incision in a patient's groin, wherein the delivery catheter has a prosthetic device positioned along a distal end. The prosthetic device includes an insert member and an anchoring member. The insert member is positioned between the native heart valve and is allowed to self-expand. The anchoring member is preferably a stent connected to the insert member by at least one elongate member. The stent is deployed within an adjacent blood vessel for anchoring the insert member between the native leaflets. After deployment of the prosthetic device, the native leaflets of the heart valve form a tight seal against the insert member for preventing regurgitation through the native heart valve during ventricular systole.

    Method for Implanting a Prosthetic Mitral Valve
    27.
    发明申请
    Method for Implanting a Prosthetic Mitral Valve 有权
    植入假体二尖瓣的方法

    公开(公告)号：US20140012373A1

    公开(公告)日：2014-01-09

    申请号：US14025701

    申请日：2013-09-12

    Applicant: Edwards Lifesciences Corporation

    Inventor： Mark Chau ,  Marlowe E. Patterson ,  Seung-Beom Yi ,  Stephen C. Geist ,  Travis Oba ,  David L. Hauser

    IPC: A61F2/24

    CPC classification number: A61F2/2412 ,  A61F2/2409 ,  A61F2/2418 ,  A61F2/2427 ,  A61F2/2445 ,  A61F2/246 ,  A61F2210/0014 ,  A61F2220/0008 ,  A61F2220/0016 ,  A61F2230/0069 ,  A61F2250/006 ,  A61F2250/0063

    Abstract: Embodiments of a method for implanting a prosthetic valve at the native mitral valve region of the heart, the prosthetic valve including a main body that is radially compressible to a radially compressed state and self-expandable from the compressed state to a radially expanded state. The prosthetic apparatus also comprises at least one ventricular anchor coupled to the main body and disposed outside of the main body with a leaflet-receiving space between the anchor and an outer surface of the main body to receive a native valve leaflet. Apparatus for delivering and implanting the prosthetic valve are also described.

    Abstract translation: 用于在心脏的天然二尖瓣区域植入人工瓣膜的方法的实施例，所述假体瓣膜包括可径向压缩到径向压缩状态并且可从压缩状态自发展到径向扩张状态的主体。 假体装置还包括耦合到主体并且设置在主体外部的至少一个心室锚固体，其具有在锚固体和主体的外表面之间的小叶容纳空间，以接收天然瓣膜小叶。 还描述了用于输送和植入人造瓣膜的装置。

    PROSTHETIC HEART VALVE THAT REDUCES NATIVE ANNULUS
    28.
    发明申请
    PROSTHETIC HEART VALVE THAT REDUCES NATIVE ANNULUS 有权

    公开(公告)号：US20250107892A1

    公开(公告)日：2025-04-03

    申请号：US18981479

    申请日：2024-12-14

    Applicant: EDWARDS LIFESCIENCES CORPORATION

    Inventor： David L. Hauser ,  David Robert Landon ,  Rani Abdullah Mahmoudi ,  Eric Robert Dixon

    IPC: A61F2/24

    Abstract: A prosthetic heart valve configured to be expanded within a native valve annulus, engage surrounding tissue, and constricted tissue inward to enhance contact between the tissue and the valve. The heart valve may have a structural valve stent with an outer constricting structure having tissue-engaging members or anchors. The constricting structure may be intrinsic or extrinsic. One intrinsic version includes a plurality of arms that are arranged to constrict inward toward a central valve portion, or a fabric structure with tissue anchors and surrounding an inner valve member may be cinched to pull the tissue inward. The anchors may engage tissue around the annulus in the atrium, or surround leaflets in the ventricle, or grasp leaflets from within.

    Method of treating a defective heart valve
    29.
    发明授权
    Method of treating a defective heart valve 有权

    公开(公告)号：US11839545B2

    公开(公告)日：2023-12-12

    申请号：US17496649

    申请日：2021-10-07

    Applicant: Edwards Lifesciences Corporation

    Inventor： David L. Hauser ,  Jan Otto Solem ,  David Alon

    IPC: A61F2/24

    CPC classification number: A61F2/246 ,  A61F2/2418 ,  A61F2/2436 ,  A61F2/2445 ,  A61F2/2466 ,  A61F2/2412 ,  A61F2210/0014 ,  A61F2220/0008 ,  A61F2220/0016

    Abstract: A method of treating a defective heart valve includes inserting a delivery catheter through a small incision in a patient's groin, wherein the delivery catheter has a prosthetic device positioned along a distal end. The prosthetic device includes an insert member and an anchoring member. The insert member self-expands to plug gaps between leaflets of the heart valve. The anchoring member is preferably a stent connected to the insert member by at least one elongate member. The stent is deployed within an adjacent blood vessel for anchoring the insert member. After deployment of the prosthetic device, the leaflets of the heart valve form a tight seal against the insert member for preventing regurgitation when the leaflets are closed and wherein blood passes through the insert member when the leaflets are open.

    Mitral valve prosthesis
    30.
    发明授权
    Mitral valve prosthesis 有权

    公开(公告)号：US10583009B2

    公开(公告)日：2020-03-10

    申请号：US16593360

    申请日：2019-10-04

    Applicant: Edwards Lifesciences Corporation

    Inventor： David L. Hauser ,  Jan Otto Solem ,  David Alon

    IPC: A61F2/24

    Abstract: A method of treating a defective mitral valve includes percutaneously advancing a prosthetic device into a patient's heart. The prosthetic device includes an insert member and anchoring member. The prosthetic device is contained within a sheath along a distal end of a delivery catheter during advancement. The anchoring member is secured to a muscular wall of the left ventricle and the insert member self-expands between native leaflets of the mitral valve. The insert member preferably includes a biocompatible fabric outer layer, a passageway, and a valve member disposed within the passageway. After deployment, the native leaflets of the mitral valve form a tight seal against the fabric outer layer of the insert member for preventing regurgitation, while blood passes through the passageway of the insert member for allowing blood to pass from the left atrium to the left ventricle.

Patent Agency Ranking